NFKB1 and hepatocellular carcinoma: Consistent with before finding, we found that IF1 promoted the EMT and angiogenesis of HCC cells and attenuated sensitivity of sorafenib to inhibit growth and metastasis in HCC through NF-κB signal pathways.